HLA
HPTX

Hamilton Lane Advisors’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Hamilton Lane Advisors’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-38,265
Closed -$999K – 79
2014
Q2 		$999K Sell
38,265
-1,068
-3% -$27.5K 0.31% 37
2014
Q1 		$1.01M Buy
+39,333
New +$1.07M 0.41% 46

Other funds holding HPTX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
HMPV
Highland Management Partners VII Cambridge, Massachusetts $5.57M AUM 94.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Hamilton Lane Advisors's HPTX Position: Q3 2014 in Review

Hamilton Lane Advisors sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q3 2014, closing a stake of 38,265 shares — an estimated $999K sold.

Hamilton Lane Advisors first reported a position in HPTX in Q1 2014 and held it in 2 quarters. The position peaked at $1.01M in Q1 2014. 97 funds tracked by Wall St. Rank hold HPTX as of Q3 2014.

  • Hamilton Lane Advisors reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Hamilton Lane Advisors sold 38,265 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q3 2014, an estimated $999K.
  • Hamilton Lane Advisors first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q1 2014 and held it in 2 quarters.
  • Hamilton Lane Advisors's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $1.01M in Q1 2014.
  • 97 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q3 2014.

Based on Hamilton Lane Advisors's 13F filing for Q3 2014, filed 6 Oct 2014.